MedTrace Logo

An Investigator-initiated, Explorative Trial Evaluating the Effect of SAT-008 in Healthy Adults

NCT04916145 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2021-06-07

No results posted yet for this study

Summary

The purpose of this exploratory study is to evaluate the efficacy, safety, and feasibility of a novel digital device called SAT-008 in healthy adults.

Conditions

  • Allergy and Immunology

Interventions

DEVICE

SAT-008

SAT-008 is a digital device containing several types of activities related to the immune function of adults.

Sponsors & Collaborators

  • Korea University Guro Hospital

    collaborator OTHER

  • S-Alpha Therapeutics, Inc.

    collaborator INDUSTRY

  • Seoul National University Bundang Hospital

    lead OTHER

Principal Investigators

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-08
Primary Completion
2021-01-25
Completion
2021-01-25

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04916145 on ClinicalTrials.gov